Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
(1) SPG20 was cleaved in HCVcc-infected Huh-7.5 cells. (2) Transient expression of HCV NS3/4A resulted in cleavage of SPG20. (3) Inactive mutant NS3/4A did not cleave SPG20. (4) NS3/4A inhibitor inhibited cleavage of SPG20, whereas NS5A inhibitor did not inhibit cleavage of SPG20. (5) Treatment of the HCVcc-infected Huh-7.5 cells decreased the size of lipid droplets. Taken together, our results suggest that HCV NS3/4A cleaves SPG20 thereby promoting enlargement of lipid droplet in HCV-infected cells.
|